Cargando…

Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer

INTRODUCTION: Improving the early prediction of neoadjuvant chemotherapy (NAC) efficacy in breast cancer can lead to an improved prediction of the final prognosis of patients, which would be useful for promoting individualized treatment. This study aimed to explore the value of the combination of dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xinhong, Chen, Xiaofeng, Yang, Zhiqi, Liao, Yuting, Wang, Mengzhu, Li, Yulin, Fan, Weixiong, Dai, Zhuozhi, Zhang, Yunuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716688/
https://www.ncbi.nlm.nih.gov/pubmed/36460972
http://dx.doi.org/10.1186/s12885-022-10315-x
_version_ 1784842745908559872
author Liang, Xinhong
Chen, Xiaofeng
Yang, Zhiqi
Liao, Yuting
Wang, Mengzhu
Li, Yulin
Fan, Weixiong
Dai, Zhuozhi
Zhang, Yunuo
author_facet Liang, Xinhong
Chen, Xiaofeng
Yang, Zhiqi
Liao, Yuting
Wang, Mengzhu
Li, Yulin
Fan, Weixiong
Dai, Zhuozhi
Zhang, Yunuo
author_sort Liang, Xinhong
collection PubMed
description INTRODUCTION: Improving the early prediction of neoadjuvant chemotherapy (NAC) efficacy in breast cancer can lead to an improved prediction of the final prognosis of patients, which would be useful for promoting individualized treatment. This study aimed to explore the value of the combination of dynamic contrast-enhanced (DCE)-MRI parameters and apparent diffusion coefficient (ADC) values in the early prediction of pathological complete response (pCR) to NAC for breast cancer. METHODS: A total of 119 (range, 28−69 years) patients with biopsy-proven breast cancer who received two cycles of NAC before breast surgery were retrospectively enrolled from our hospital database. Patients were divided into pCR and non pCR groups according to their pathological responses; a total of 24 patients achieved pCR, while 95 did not. The quantitative (K(trans); K(ep); V(e); IAUC) and semiquantitative parameters (W-in; W-out; TTP) of DCE-MRI that were significantly different between groups were combined with ADC values to explore their value in the early prediction of pCR to NAC for breast cancer. The independent T test was performed to compare the differences in DCE-MRI parameters and ADC values between the two groups. Receiver operating characteristic (ROC) curves were plotted, and the area under the ROC curve (AUC), sensitivity and specificity were calculated to evaluate the performance of the prediction. RESULTS: The K(trans), K(ep), IAUC, ADC, W-in and TTP values were significantly different between the pCR and non pCR groups after NAC. The AUC (0.845) and specificity (95.79%) of the combined K(trans), K(ep), IAUC and ADC values were both higher than those of the individual parameters. The combination of W-in, TTP and ADC values had the highest AUC value (0.886) in predicting pCR, with a sensitivity and specificity of 87.5% and 82.11%, respectively. CONCLUSIONS: The results suggested that the combination of ADC values and quantitative and semiquantitative DCE-MRI parameters, especially the combination of W-in, TTP, and ADC values, may improve the early prediction of pCR in breast cancer.
format Online
Article
Text
id pubmed-9716688
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97166882022-12-03 Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer Liang, Xinhong Chen, Xiaofeng Yang, Zhiqi Liao, Yuting Wang, Mengzhu Li, Yulin Fan, Weixiong Dai, Zhuozhi Zhang, Yunuo BMC Cancer Research INTRODUCTION: Improving the early prediction of neoadjuvant chemotherapy (NAC) efficacy in breast cancer can lead to an improved prediction of the final prognosis of patients, which would be useful for promoting individualized treatment. This study aimed to explore the value of the combination of dynamic contrast-enhanced (DCE)-MRI parameters and apparent diffusion coefficient (ADC) values in the early prediction of pathological complete response (pCR) to NAC for breast cancer. METHODS: A total of 119 (range, 28−69 years) patients with biopsy-proven breast cancer who received two cycles of NAC before breast surgery were retrospectively enrolled from our hospital database. Patients were divided into pCR and non pCR groups according to their pathological responses; a total of 24 patients achieved pCR, while 95 did not. The quantitative (K(trans); K(ep); V(e); IAUC) and semiquantitative parameters (W-in; W-out; TTP) of DCE-MRI that were significantly different between groups were combined with ADC values to explore their value in the early prediction of pCR to NAC for breast cancer. The independent T test was performed to compare the differences in DCE-MRI parameters and ADC values between the two groups. Receiver operating characteristic (ROC) curves were plotted, and the area under the ROC curve (AUC), sensitivity and specificity were calculated to evaluate the performance of the prediction. RESULTS: The K(trans), K(ep), IAUC, ADC, W-in and TTP values were significantly different between the pCR and non pCR groups after NAC. The AUC (0.845) and specificity (95.79%) of the combined K(trans), K(ep), IAUC and ADC values were both higher than those of the individual parameters. The combination of W-in, TTP and ADC values had the highest AUC value (0.886) in predicting pCR, with a sensitivity and specificity of 87.5% and 82.11%, respectively. CONCLUSIONS: The results suggested that the combination of ADC values and quantitative and semiquantitative DCE-MRI parameters, especially the combination of W-in, TTP, and ADC values, may improve the early prediction of pCR in breast cancer. BioMed Central 2022-12-02 /pmc/articles/PMC9716688/ /pubmed/36460972 http://dx.doi.org/10.1186/s12885-022-10315-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liang, Xinhong
Chen, Xiaofeng
Yang, Zhiqi
Liao, Yuting
Wang, Mengzhu
Li, Yulin
Fan, Weixiong
Dai, Zhuozhi
Zhang, Yunuo
Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title_full Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title_fullStr Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title_full_unstemmed Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title_short Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
title_sort early prediction of pathological complete response to neoadjuvant chemotherapy combining dce-mri and apparent diffusion coefficient values in breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716688/
https://www.ncbi.nlm.nih.gov/pubmed/36460972
http://dx.doi.org/10.1186/s12885-022-10315-x
work_keys_str_mv AT liangxinhong earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT chenxiaofeng earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT yangzhiqi earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT liaoyuting earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT wangmengzhu earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT liyulin earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT fanweixiong earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT daizhuozhi earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer
AT zhangyunuo earlypredictionofpathologicalcompleteresponsetoneoadjuvantchemotherapycombiningdcemriandapparentdiffusioncoefficientvaluesinbreastcancer